Notices. DEPARTMENT OF JUSTICE
508 words·~2 min read·
/register/2004/10/14/04-23053·A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
BILLING CODE 4410-09-P DEPARTMENT OF JUSTICE Drug Enforcement Administration Manufacturer of Controlled Substances; Notice of Application Pursuant to 21 CFR 1301.33(a), this is notice that on July 6, 2004, Cerilliant Corporation, 811 Paloma Drive, Suite A, Round Rock, Texas 78664, made application by renewal to the Drug Enforcement Administration
(DEA)for registration as a bulk manufacturer of the basic classes of controlled substances listed: Drug Schedule Cathinone
(1235)I Methcathinone
(1237)I N-Ethylamphetamine
(1475)I N,N-Dimethylamphetamine
(1480)I Aminorex
(1585)I 4-Methylaminorex (cis isomer)
(1590)I Gamma hydroxybutyric acid
(2010)I Methaqualone
(2565)I Alpha-Ethyltryptamine
(7249)I Lysergic acid diethylamide
(7315)I Tetrahydrocannabinols
(7370)I Mescaline
(7381)I 3,4,5-Trimethoxyamphetamine
(7390)I 4-Bromo-2,5-dimethoxyamphetamine
(7391)I 4-Bromo-2,5-dimethoxyphenethylamine
(7392)I 4-Methyl-2,5-dimethoxyamphetamine
(7395)I 2,5-Dimethoxyamphetamine
(7396)I 2,5-Dimethoxy-4-ethylamphetamine
(7399)I 3,4-Methylenedioxyamphetamine
(7400)I 5-Methoxy-3,4-methylenedioxyamphetamine
(7401)I N-Hydroxy-3,4-methylendioxyamphetamine
(7402)I 3,4-Methylendioxy-N-ethylamphetamine
(7404)I 3,4-Methylenedioxymetham- phetamine
(7405)I 4-Methoxyamphetamine
(7411)I Bufotenine
(7433)I Diethyltryptamine
(7434)I Dimethyltryptamine
(7435)I Psilocybin
(7437)I Psilocyn
(7438)I Acetyldihydrocodeine
(9051)I Benzylmorphine
(9052)I Codeine-N-oxide
(9053)I Dihydromorphine
(9145)I Heroin
(9200)I Hydromorphinol
(9301)I Methyldihydromorphine
(9304)I Morphine-N-oxide
(9307)I Normorphine
(9313)I Pholcodine
(9314)I Acetylmethadol
(9601)I Allylprodine
(9602)I Alphacetylmethadol except levo-alphacetylmethadol
(9603)I Alphameprodine
(9604)I Alphamethadol
(9605)I Betacetylmethadol
(9607)I Betameprodine
(9608)I Betamethadol
(9609)I Betaprodine
(9611)I Hydroxypethidine
(9627)I Noracymethadol
(9633)I Norlevorphanol
(9634)I Normethadone
(9635)I Trimeperidine
(9646)I Phenomorphan
(9647)I Para-Fluorofentanyl
(9812)I 3-Methylfentanyl
(9813)I Alpha-Methylfentanyl
(9814)I Acetyl-alpha-methylfentanyl
(9815)I Beta-hydroxyfentanyl
(9830)I Beta-hydroxy-3-methylfentanyl
(9831)I Alpha-Methylthiofentanyl
(9832)I 3-Methylthiofentanyl
(9833)I Thiofentanyl
(9835)I Amphetamine
(1100)II Methamphetamine
(1105)II Phenmetrazine
(1631)II Methylphenidate
(1724)II Ambobarbital
(2125)II Pentobarbital
(2270)II Secobarbital
(2315)II Glutethimide
(2550)II Nabilone
(7379)II 1-Phenylcyclohexylamine
(7460)II Phencyclidine
(7471)II 1-Piperidinocyclohexane- carbonitrile
(8603)II Alphaprodine
(9010)II Cocaine
(9041)II Codeine
(9050)II Dihydrocodeine
(9120)II Oxycodone
(9143)II Hydromorphone
(9150)II Diphenoxylate
(9170)II Benzoylecgonine
(9180)II Ethylmorphine
(9190)II Hydrocodone
(9193)II Levomethorphan
(9210)II Levorphanol
(9220)II Isomethadone
(9226)II Meperidine
(9230)II Methadone
(9250)II Methadone-intermediate
(9254)II Dextropropoxyphene, bulk (non-dosage forms)
(9273)II Morphine
(9300)II Thebaine
(9333)II Levo-alphacetylmethadol
(9648)II Oxymorphone
(9652)II Noroxymorphone
(9668)II Racemethorphan
(9732)II Alfentanil
(9737)II Sufentanil
(9740)II Fentanyl
(9801)II The company plans to manufacture small quantities of the listed controlled substances to make reference standards for distribution to their customers. Any other such applicant and any person who is presently registered with DEA to manufacture such a substance may file comments or objections to the issuance of the proposed registration pursuant to 21 CFR 1301.33(a). Any such comments or objections may be addressed, in quintuplicate, to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, United States Department of Justice, Washington, DC 20537, Attention: DEA **Federal Register** Representative
(CCD)and must be filed no later than December 13, 2004. Dated: September 28, 2004. William J. Walker, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 04-23053 Filed 10-13-04; 8:45 am]
Connectionstraces to 1
Traces to 1 document
Citation graph
cites case law
Notices
DEPARTMENT OF JUSTICE
Cites 1Cited by 0 across 0 sources